ArticleClinical, cosmetic and investigational dermatology2024

Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases.

Jingyao Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.